{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:04Z","timestamp":1792787284891,"version":"4.5.0"},"reference-count":29,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["EOS 30770923"],"award-info":[{"award-number":["EOS 30770923"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["WELBIO-CR-2019C-02R"],"award-info":[{"award-number":["WELBIO-CR-2019C-02R"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Funds Baillet Latour","award":["Grant for Medical Research 2015"],"award-info":[{"award-number":["Grant for Medical Research 2015"]}]},{"name":"Agence Nationale de la Recherche","award":["ANR-18-CE14-0007-01"],"award-info":[{"award-number":["ANR-18-CE14-0007-01"]}],"id":[{"id":"https:\/\/ror.org\/00rbzpz17","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2020,8,26]]},"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The enteric nervous system (ENS) plays a key role in controlling the gut-brain axis under normal and pathological conditions, such as type 2 diabetes. The discovery of intestinal actors, such as enterosynes, able to modulate the ENS-induced duodenal contraction is considered an innovative approach. Among all the intestinal factors, the understanding of the role of gut microbes in controlling glycaemia is still developed. We studied whether the modulation of gut microbiota by prebiotics could permit the identification of novel enterosynes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We measured the effects of prebiotics on the production of bioactive lipids in the intestine and tested the identified lipid on ENS-induced contraction and glucose metabolism. Then, we studied the signalling pathways involved and compared the results obtained in mice to human.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that modulating the gut microbiota with prebiotics modifies the actions of enteric neurons, thereby controlling duodenal contraction and subsequently attenuating hyperglycaemia in diabetic mice. We discovered that the signalling pathway involved in these effects depends on the synthesis of a bioactive lipid 12-hydroxyeicosatetraenoic acid (12-HETE) and the presence of mu-opioid receptors (MOR) on enteric neurons. Using pharmacological approaches, we demonstrated the key role of the MOR receptors and proliferator-activated receptor \u03b3 for the effects of 12-HETE. These findings are supported by human data showing a decreased expression of the proenkephalin and MOR messanger RNAs in the duodenum of patients with diabetic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Using a prebiotic approach, we identified enkephalin and 12-HETE as new enterosynes with potential real beneficial and safety impact in diabetic human.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2019-320230","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:25:15Z","timestamp":1601943915000},"page":"1078-1087","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["Identification of new enterosynes using prebiotics: roles of bioactive lipids and mu-opioid receptor signalling in humans and mice"],"prefix":"10.1136","volume":"70","author":[{"given":"Anne","family":"Abot","sequence":"first","affiliation":[{"name":"IRSD, INSERM, Toulouse, Occitanie, France"},{"name":"Enterosys, CRO, Toulouse, Occitanie, France"},{"name":"European Associated Laboratory (EAL) NeuroMicrobiota, Toulouse, Brussels, France, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Wemelle","sequence":"additional","affiliation":[{"name":"IRSD, INSERM, Toulouse, Occitanie, France"},{"name":"European Associated Laboratory (EAL) NeuroMicrobiota, Toulouse, Brussels, France, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Laurens","sequence":"additional","affiliation":[{"name":"CNRS, University of Strasbourg, Strasbourg, France"},{"name":"CNES, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Paquot","sequence":"additional","affiliation":[{"name":"Bioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, UCLouvain, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pomie","sequence":"additional","affiliation":[{"name":"Enterosys, CRO, Toulouse, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Carper","sequence":"additional","affiliation":[{"name":"I2MC, INSERM, Toulouse, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Bessac","sequence":"additional","affiliation":[{"name":"IRSD, INSERM, Toulouse, Occitanie, France"},{"name":"IPBS, Toulouse, Midi-Pyr\u00e9n\u00e9es, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mas Orea","sequence":"additional","affiliation":[{"name":"IRSD, INSERM, Toulouse, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Fremez","sequence":"additional","affiliation":[{"name":"Enterosys, CRO, Toulouse, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Fontanie","sequence":"additional","affiliation":[{"name":"Enterosys, CRO, Toulouse, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Lucas","sequence":"additional","affiliation":[{"name":"I2MC, INSERM, Toulouse, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Lesage","sequence":"additional","affiliation":[{"name":"Lille 2 University of Health and Law, Lille, Hauts-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Everard","sequence":"additional","affiliation":[{"name":"Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Walloon Excellence in Life Sciences and BIOtechnology (WELBIO), UCLouvain, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Meunier","sequence":"additional","affiliation":[{"name":"IPBS, Toulouse, Midi-Pyr\u00e9n\u00e9es, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Dietrich","sequence":"additional","affiliation":[{"name":"IRSD, INSERM, Toulouse, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1600-9259","authenticated-orcid":false,"given":"Giulio G","family":"Muccioli","sequence":"additional","affiliation":[{"name":"Bioanalysis and Pharmacology of Bioactive Lipids Research Group, Louvain Drug Research Institute, UCLouvain, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Moro","sequence":"additional","affiliation":[{"name":"I2MC, INSERM, Toulouse, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2040-2448","authenticated-orcid":false,"given":"Patrice D","family":"Cani","sequence":"additional","affiliation":[{"name":"European Associated Laboratory (EAL) NeuroMicrobiota, Toulouse, Brussels, France, Belgium"},{"name":"Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Walloon Excellence in Life Sciences and BIOtechnology (WELBIO), UCLouvain, Universit\u00e9 catholique de Louvain, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5213-5378","authenticated-orcid":false,"given":"Claude","family":"Knauf","sequence":"additional","affiliation":[{"name":"IRSD, INSERM, Toulouse, Occitanie, France"},{"name":"European Associated Laboratory (EAL) NeuroMicrobiota, Toulouse, Brussels, France, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,5]]},"reference":[{"key":"2026092408351429000_70.6.1078.1","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-017-0853-8","article-title":"Should side effects influence the selection of antidiabetic therapies in type 2 diabetes?","volume":"17","author":"Grunberger","year":"2017","journal-title":"Curr Diab Rep"},{"key":"2026092408351429000_70.6.1078.2","doi-asserted-by":"publisher","DOI":"10.2174\/1389450119666180621093833"},{"key":"2026092408351429000_70.6.1078.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.03.056"},{"key":"2026092408351429000_70.6.1078.4","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00328","article-title":"Impact of intestinal peptides on the enteric nervous system: novel approaches to control glucose metabolism and food intake","volume":"9","author":"Abot","year":"2018","journal-title":"Front Endocrinol"},{"key":"2026092408351429000_70.6.1078.5","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310230"},{"key":"2026092408351429000_70.6.1078.6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.molmet.2018.01.020","article-title":"Galanin enhances systemic glucose metabolism through enteric nitric oxide Synthase-expressed neurons","volume":"10","author":"Abot","year":"2018","journal-title":"Mol Metab"},{"key":"2026092408351429000_70.6.1078.7","doi-asserted-by":"publisher","DOI":"10.1159\/000500602"},{"key":"2026092408351429000_70.6.1078.8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.molmet.2016.05.011","article-title":"How gut microbes talk to organs: the role of endocrine and nervous routes","volume":"5","author":"Cani","year":"2016","journal-title":"Mol Metab"},{"key":"2026092408351429000_70.6.1078.9","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00280"},{"key":"2026092408351429000_70.6.1078.10","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.01765","article-title":"Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila","volume":"8","author":"Cani","year":"2017","journal-title":"Front Microbiol"},{"key":"2026092408351429000_70.6.1078.11","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.75"},{"key":"2026092408351429000_70.6.1078.12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s42255-018-0017-4","article-title":"Microbial regulation of organismal energy homeostasis","volume":"1","author":"Cani","year":"2019","journal-title":"Nat Metab"},{"key":"2026092408351429000_70.6.1078.13","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12534"},{"key":"2026092408351429000_70.6.1078.14","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2015.204","article-title":"Neurogastroenterology: improving glucose tolerance via the gut-brain axis","volume":"13","author":"Weber","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026092408351429000_70.6.1078.15","doi-asserted-by":"publisher","DOI":"10.1007\/s000110050367"},{"key":"2026092408351429000_70.6.1078.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1219451110"},{"key":"2026092408351429000_70.6.1078.17","doi-asserted-by":"publisher","DOI":"10.1210\/en.2012-2029"},{"key":"2026092408351429000_70.6.1078.18","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M053058"},{"key":"2026092408351429000_70.6.1078.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.04.039"},{"key":"2026092408351429000_70.6.1078.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.05.039"},{"key":"2026092408351429000_70.6.1078.21","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1017\/S0007114512004047","article-title":"Gut microbiota and metabolic disorders: how prebiotic can work?","volume":"109 Suppl 2","author":"Delzenne","year":"2013","journal-title":"Br J Nutr"},{"key":"2026092408351429000_70.6.1078.22","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00182","article-title":"Is there a role for bioactive lipids in the pathobiology of diabetes mellitus?","volume":"8","author":"Das","year":"2017","journal-title":"Front Endocrinol"},{"key":"2026092408351429000_70.6.1078.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2014.10.008"},{"key":"2026092408351429000_70.6.1078.24","first-page":"171","article-title":"Involvement of mu opioid receptor signaling in the protective effect of opioid against 6-hydroxydopamine-induced SH-SY5Y human neuroblastoma cells apoptosis","volume":"6","author":"Eftekhar-Vaghefi","year":"2015","journal-title":"Basic Clin Neurosci"},{"key":"2026092408351429000_70.6.1078.25","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13497"},{"key":"2026092408351429000_70.6.1078.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2007.01023.x"},{"key":"2026092408351429000_70.6.1078.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-017-1341-2"},{"key":"2026092408351429000_70.6.1078.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.04.054"},{"key":"2026092408351429000_70.6.1078.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0791-0"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2019-320230","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:37:22Z","timestamp":1790264242000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2019-320230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,5]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,5,7]]},"published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1136\/gutjnl-2019-320230"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2019-320230","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,5]]}}}